Clinical trial

Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients

NCT01441752

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention TCM Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-11-01

PhasePHASE3

Conditions

Non-small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Interventions

TCMDRUG

placeboDRUG

Sponsors & collaborators

xulinglead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01441752 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.